Literature DB >> 28560656

Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Devika R Jutagir1, Bonnie B Blomberg2,3, Charles S Carver1,2, Suzanne C Lechner2, Kiara R Timpano1, Laura C Bouchard1, Lisa M Gudenkauf1, Jamie M Jacobs4, Alain Diaz3, Susan K Lutgendorf5, Steve W Cole6, Aaron S Heller1,2, Michael H Antoni7,8.   

Abstract

PURPOSE: Satisfaction with social resources, or "social well-being," relates to better adaptation and longer survival after breast cancer diagnosis. Biobehavioral mechanisms linking social well-being (SWB) to mental and physical health may involve inflammatory signaling. We tested whether reports of greater SWB were associated with lower levels of pro-inflammatory and pro-metastatic leukocyte gene expression after surgery for non-metastatic breast cancer.
METHODS: Women (N = 50) diagnosed with non-metastatic (0-III) breast cancer were enrolled 2-8 weeks after surgery. SWB was assessed with the social/family well-being subscale of the FACT-B. Leukocyte gene expression for specific pro-inflammatory (cytokines, chemokines, and COX-2) and pro-metastatic genes (e.g., MMP9) was derived from microarray analysis.
RESULTS: Multiple regression analyses controlling for age, stage of disease, days since surgery, education, and body mass index (BMI) found higher levels of SWB related to less leukocyte pro-inflammatory and pro-metastatic gene expression (p < 0.05). Emotional well-being, physical well-being, and functional well-being did not relate to leukocyte gene expression (p > 0.05). Greater SWB remained significantly associated with less leukocyte pro-inflammatory and pro-metastatic gene expression after controlling for depressive symptoms.
CONCLUSIONS: Results have implications for understanding mechanisms linking social resources to health-relevant biological processes in breast cancer patients undergoing primary treatment. CLINICAL TRIAL REGISTRATION NUMBER: NCT01422551.

Entities:  

Keywords:  Breast cancer; Inflammation; Leukocyte gene expression; Social support; Social well-being

Mesh:

Substances:

Year:  2017        PMID: 28560656      PMCID: PMC5528864          DOI: 10.1007/s10549-017-4316-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

Authors:  Robert D Berahovich; Brian A Zabel; Susanna Lewén; Matthew J Walters; Karen Ebsworth; Yu Wang; Juan C Jaen; Thomas J Schall
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

2.  Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention.

Authors:  Brittany M Brothers; Hae-Chung Yang; Daniel R Strunk; Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2011-04

3.  A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Authors:  Dominique L Musselman; Wendy I Somerset; Ying Guo; Amita K Manatunga; Maryfrances Porter; Suzanne Penna; Barbara Lewison; Rebecca Goodkin; Kathryn Lawson; David Lawson; Dwight L Evans; Charles B Nemeroff
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

4.  Quality of life after breast cancer diagnosis and survival.

Authors:  Meira Epplein; Ying Zheng; Wei Zheng; Zhi Chen; Kai Gu; David Penson; Wei Lu; Xiao-Ou Shu
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

5.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

6.  Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

7.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

8.  A functional genomic perspective on human well-being.

Authors:  Barbara L Fredrickson; Karen M Grewen; Kimberly A Coffey; Sara B Algoe; Ann M Firestine; Jesusa M G Arevalo; Jeffrey Ma; Steven W Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

9.  The relationship between social ties and survival among black and white breast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group.

Authors:  P Reynolds; P T Boyd; R S Blacklow; J S Jackson; R S Greenberg; D F Austin; V W Chen; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

10.  Loneliness, eudaimonia, and the human conserved transcriptional response to adversity.

Authors:  Steven W Cole; Morgan E Levine; Jesusa M G Arevalo; Jeffrey Ma; David R Weir; Eileen M Crimmins
Journal:  Psychoneuroendocrinology       Date:  2015-07-08       Impact factor: 4.905

View more
  9 in total

1.  Trajectories of quality of life following breast cancer diagnosis.

Authors:  Neha G Goyal; Beverly J Levine; Kimberly J Van Zee; Elizabeth Naftalis; Nancy E Avis
Journal:  Breast Cancer Res Treat       Date:  2018-01-24       Impact factor: 4.872

Review 2.  An Epigenetic Perspective on Lifestyle Medicine for Depression: Implications for Primary Care Practice.

Authors:  Jenny Sunghyun Lee; Paresh Atu Jaini; Frank Papa
Journal:  Am J Lifestyle Med       Date:  2020-09-10

Review 3.  Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes.

Authors:  Aeson Chang; Erica K Sloan; Michael H Antoni; Jennifer M Knight; Rachel Telles; Susan K Lutgendorf
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

4.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

Review 5.  Living with Metastatic Cancer: A Roadmap for Future Research.

Authors:  Danielle B Tometich; Kelly A Hyland; Hatem Soliman; Heather S L Jim; Laura Oswald
Journal:  Cancers (Basel)       Date:  2020-12-08       Impact factor: 6.639

6.  Effects of psychosocial support interventions on survival in inpatient and outpatient healthcare settings: A meta-analysis of 106 randomized controlled trials.

Authors:  Timothy B Smith; Connor Workman; Caleb Andrews; Bonnie Barton; Matthew Cook; Ryan Layton; Alexandra Morrey; Devin Petersen; Julianne Holt-Lunstad
Journal:  PLoS Med       Date:  2021-05-18       Impact factor: 11.069

7.  Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients.

Authors:  Joaquim C Reis; Luzia Travado; Elsa Seixas; Berta Sousa; Michael H Antoni
Journal:  Brain Behav Immun Health       Date:  2022-02-22

Review 8.  Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper.

Authors:  Sindhuja Kadambi; Enrique Soto-Perez-de-Celis; Tullika Garg; Kah Poh Loh; Jessica L Krok-Schoen; Nicolò Matteo Luca Battisti; Gordon Taylor Moffat; Luiz A Gil-Jr; Supriya Mohile; Tina Hsu
Journal:  J Geriatr Oncol       Date:  2019-10-15       Impact factor: 3.929

9.  Baseline pro-inflammatory gene expression in whole blood is related to adverse long-term outcomes after transcatheter aortic valve replacement: a case control study.

Authors:  Deena S Goldwater; Mei Leng; Arun Karlamangla; Teresa Seeman; David Elashoff; Jonathan M Wanagat; David B Reuben; Brian R Lindman; Steve Cole
Journal:  BMC Cardiovasc Disord       Date:  2021-08-02       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.